CARLSBAD, Calif. & IRVINE, Calif.--(BUSINESS WIRE)--

Applied Spectral Imaging Inc. (ASI) and BioDot Inc. have entered into an agreement in which both companies will engage in combined sales and marketing of an integration product that will directly link the GenASIs imaging and analysis instrument by ASI and the CellWriter automated dispensing system for FISH and Karyotyping by BioDot. The combined solution enables an end-to-end, automated workflow for FISH and Karyotyping, from slide production to sample analysis and result reporting.

Personalized medicine challenges laboratories to continuously expand their genetic analysis throughput rapidly and cost effectively. The ASI and BioDot platforms provide an end-to-end environment for managing samples from slide preparation to the generation of the analysis report. said Limor Shiposh, CEO of Applied Spectral Imaging Inc. Our combined offering for automated genetic analysis leverages the imaging and analysis accuracy, speed and quality results of ASIs GenASIs platform with the flexibility, efficiency and simplicity of BioDots CellWriter automated dispensing system for FISH and Karyotyping added Mrs. Shiposh.

We are excited to work with ASI on a combined automated workflow solution for FISH and Karyotyping. The cytogenetics workflow is highly complex and by integrating automated slide processing with automated microscopy, we can now deliver a data management product that greatly simplifies the scientists workday. BioDots CellWriter is able to automate cell dropping to deliver quality spread interphase and metaphase nuclei for analysis, bridging the automation gap between harvesting and automated microscopy, and bringing high throughput processing to this market. said Tom Tisone, CEO of BioDot Inc.

ASI and BioDot have confirmed the combined solutions effectiveness in performing automated FISH and karyotyping. As a part of the new product offering, the two companies will offer a set of software connectors enabling bidirectional and seamless data integration between the two solutions.

About Applied Spectral Imaging

Applied Spectral Imaging (ASI) makes patient care better through advanced biomedical imaging.

GenASIs by ASI is FDA cleared for FISH clinical applications such as ALK, UroVysion, HER2/neu, CEP XY and Karyotyping. ASI complies with major regulatory requirements and international quality standards.

ASI has been one of the industry's leading microscopy imaging solution providers since 1993, with over 30 registered patents in the US, Europe and Japan and over 2,500 systems deployed worldwide. With worldwide offices in the US, Europe and Asia, ASI has built a global network of over 50 distributors.

About BioDot

View post:
BioDot and Applied Spectral Imaging Cooperate to Deliver Automated Genetic Analysis Solution

Comments are closed.